Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
GSK's Arexvy dominates RSV market ahead of new competition
The company's respiratory syncytial virus vaccine Arexvy takes some two-thirds of the RSV market share, GSK reported.
Zoey Becker
May 1, 2024 11:20am
FTC targets Novo's Ozempic among 300-plus 'junk' patents
May 1, 2024 7:30am
Pfizer takes top spot in docs' vaccine ranking by 'huge margin'
May 1, 2024 7:00am
CPI unveils next leg of its digital manufacturing journey
Apr 30, 2024 10:23am
GSK launches mRNA patent infringement case against Pfizer
Apr 26, 2024 10:04am
AstraZeneca and Merck's Lynparza set to 'dominate' PARP market
Apr 24, 2024 8:23am